Scientific Reports Publishes INFORAAA Results
/PRNewswire/ -- Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of...
Source: prnewswire.com
📰 Nasdaq First News
Page 22 - Nasdaq First News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq First. Real-time updates on events, politics, business and more.
Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Juho Jalkanen Appointed Chief Operating Officer
Investegate announcements from Faron Pharma. Oy, Juho Jalkanen Appointed Chief Operating Officer
Source: investegate.co.uk
Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron at Proactive One2One Investor Forum
Investegate announcements from Faron Pharma. Oy, Faron at Proactive One2One Investor Forum
Source: investegate.co.uk
Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron to Present at Redeye Fight Cancer Seminar
Investegate announcements from Faron Pharma. Oy, Faron to Present at Redeye Fight Cancer Seminar
Source: investegate.co.uk
Enzymatica AB: Enzymatica comments on wrongful wording in Dagens Medicin
STOCKHOLM, Jan. 12, 2022 /PRNewswire/ -- The headline and introduction of an article today on the webpage of the Swedish magazine Dagens Medicin wrongfully claim that a study on ColdZyme has
Claus Egstrand Fredrik Lindberg Coldzyme Munspray Stefan Olsson Dagens Medicin Nordic Association Of Otolaryngology
Source: finanznachrichten.de
Faron Appoints Marie-Louise Fjällskog as CMO
/PRNewswire/ -- Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of...
Source: prnewswire.com
Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron's financial calendar for 2022
Investegate announcements from Faron Pharma. Oy, Farons financial calendar for 2022
Source: investegate.co.uk
Faron Announces Topline MATINS Biomarker Analysis
/PRNewswire/ -- Faron Pharmaceuticals Ltd. ("Faron") Topline Biomarker Analysis Shows Bexmarilimab Ignites Immune Response in Patient Population That Has Not...
Source: prnewswire.com
Faron Announces Topline MATINS Biomarker Analysis
/PRNewswire/ -- Faron Pharmaceuticals Ltd. ("Faron") Topline Biomarker Analysis Shows Bexmarilimab Ignites Immune Response in Patient Population That Has Not...
Source: prnewswire.com
Hilbert Group Publishes Interim Report for Q3 and The First Nine Months of 2021
STOCKHOLM, SE / ACCESSWIRE / November 30, 2021 / Hilbert Group (STO:HILB-B)The third quarterRevenue amounted to kSEK 832.9 (-)Operating profit/loss (EBIT) totaled kSEK -2,936.1 (-102.2)EBIT was affected
Niclas Sandstr Eminova Fondkommission Hilbert Group Interim Report Hilbert Group Nasdaq First North Growth Market Asset Management
Source: finanznachrichten.de